middle.news
Entropy Neurodynamics Reports Promising Early Results in TRP-8803 BED Trial
10:14am on Tuesday 28th of April, 2026 AEST
•
Biotechnology
Read Story
Entropy Neurodynamics Reports Promising Early Results in TRP-8803 BED Trial
10:14am on Tuesday 28th of April, 2026 AEST
Key Points
First patient in TRP-8803 Phase 2 BED trial shows multi-domain symptom improvement
Cohort 1 fully enrolled with dosing progressing and reproducible psychedelic responses
Peer-reviewed Phase 2a TRP-8802 data confirms rapid, sustained binge eating reductions
Australian patent granted for precision-controlled IV dosing method extending protection to 2042
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Entropy Neurodynamics (ASX:ENP)
OPEN ARTICLE